Alignment Healthcare, Inc.
▲ 0 upgrades / ▼ 1 downgrades / 5 reiterations from 6 firms
Oct 29, 2026 (3 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 12, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Oct 12, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Oct 9, 2026 | William Blair | downgrade | Outperform → Market Perform | — | 48% |
| Oct 9, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| Oct 9, 2026 | Keybanc | maintain | Overweight → Overweight | — | 53% |
| Oct 6, 2026 | Barclays | maintain | Equal-Weight → Equal-Weight | — | 53% |
| Aug 4, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| Aug 3, 2026 | Raymond James | downgrade | Strong Buy → Outperform | — | 54% |
| May 26, 2026 | Barclays | maintain | Equal-Weight → Equal-Weight | — | 53% |
| May 1, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| May 1, 2026 | Barclays | maintain | Equal-Weight → Equal-Weight | — | 53% |
| Feb 5, 2026 | JP Morgan | maintain | Overweight → Overweight | $26 | 54% |
| Jan 16, 2026 | TD Cowen | maintain | Buy → Buy | $25 | 54% |
| Jan 14, 2026 | UBS | maintain | Neutral → Neutral | $21 | 54% |
| Jan 6, 2026 | Piper Sandler | maintain | Overweight → Overweight | $30 | 54% |
| Dec 17, 2025 | JP Morgan | maintain | Overweight → Overweight | $23 | 54% |
| Nov 24, 2025 | JP Morgan | upgrade | Neutral → Overweight | $20 | 54% |
| Nov 5, 2025 | JP Morgan | maintain | Neutral → Neutral | $18 | 54% |
| Nov 3, 2025 | Barclays | maintain | Equal-Weight → Equal-Weight | $18 | 53% |
| Oct 31, 2025 | UBS | maintain | Neutral → Neutral | $18 | 54% |
| Oct 14, 2025 | Goldman Sachs | initiate | — → Buy | $21 | 54% |
| Aug 25, 2025 | Keybanc | upgrade | Sector Weight → Overweight | $21 | 53% |
| Jul 31, 2025 | Barclays | upgrade | Underweight → Equal-Weight | $13 | 53% |
| May 2, 2025 | UBS | maintain | Neutral → Neutral | $17 | 54% |
| Apr 15, 2025 | Baird | maintain | Outperform → Outperform | $22 | 55% |
| Apr 8, 2025 | Stifel | maintain | Buy → Buy | $23 | 53% |
| Mar 6, 2025 | JP Morgan | maintain | Neutral → Neutral | $17 | 54% |
| Mar 4, 2025 | Piper Sandler | maintain | Overweight → Overweight | $21 | 54% |
| Mar 4, 2025 | B of A Securities | maintain | Buy → Buy | $18.5 | 53% |
| Feb 28, 2025 | Stifel | maintain | Buy → Buy | $18 | 53% |
| Feb 28, 2025 | Barclays | maintain | Underweight → Underweight | $9 | 53% |
| Feb 24, 2025 | Stephens & Co. | reiterate | Overweight → Overweight | $17 | 54% |
| Jan 14, 2025 | Stifel | maintain | Buy → Buy | $16 | 53% |
| Jan 2, 2025 | Stephens & Co. | reiterate | Overweight → Overweight | $17 | 54% |
| Dec 3, 2024 | Stephens & Co. | upgrade | Equal-Weight → Overweight | $17 | 54% |
| Oct 31, 2024 | TD Cowen | maintain | Buy → Buy | $13 | 54% |
| Oct 30, 2024 | Barclays | maintain | Underweight → Underweight | $8 | 53% |
| Oct 30, 2024 | UBS | maintain | Neutral → Neutral | $12 | 54% |
| Oct 11, 2024 | Keybanc | initiate | — → Sector Weight | $0 | 53% |
| Aug 14, 2024 | Baird | maintain | Outperform → Outperform | $11 | 55% |
| Aug 6, 2024 | TD Cowen | maintain | Buy → Buy | $10 | 54% |
| Aug 6, 2024 | Piper Sandler | reiterate | Overweight → Overweight | $10 | 54% |
| Aug 5, 2024 | Barclays | maintain | Underweight → Underweight | $7 | 53% |
| Jul 26, 2024 | Stifel | maintain | Buy → Buy | $12 | 53% |
| May 30, 2024 | Baird | initiate | — → Outperform | $10 | 55% |
| May 8, 2024 | Piper Sandler | upgrade | Neutral → Overweight | $8 | 54% |
| May 3, 2024 | Stephens & Co. | maintain | Equal-Weight → Equal-Weight | $7 | 54% |
| Apr 23, 2024 | Stifel | maintain | Buy → Buy | $9 | 53% |
| Mar 6, 2024 | Piper Sandler | downgrade | Overweight → Neutral | $6 | 54% |
| Mar 6, 2024 | Barclays | initiate | — → Underweight | $4.5 | 53% |
No cross-platform signals in the last 90 days